NCT04889638

Brief Summary

The inequity in cessation resources is at forefront in the recently enacted nationwide smoking ban in public housing facilities. The critical component lacking from the federal decree was a practical smoking cessation strategy to address the real-world needs of active smokers who maintain cigarette usage. The investigator's proposal is ideally situated for this contemporary moment when low-income smokers in public housing are signing leases describing the potential for smoking-related evictions and thus at least contemplating smoking modification. The investigator's project is centered around the residents of Baltimore City Public Housing which is among the larger-sized U.S. public housing agencies. Using a human-centered design (HCD) approach, the investigators are refining and testing a community-centric cessation strategy defined by two core elements: a) durable and jointly linked community/hospital infrastructure systems (remote cessation specialist staffing and drug supplies) and strong on-site (public housing) residential leadership commitment to cessation improvement. These dual features, along with adaptable elements that can be modified to a variety of local/national housing settings, defines how the investigator's project will overcome the implementation gaps defining failed smoking cessation efforts in lower-income settings. The objective of this project is to test the feasibility of the intervention package among local housing contextual factors that could impact both the acceptability and adoptability of the investigator's project. Using a collection of formative and implementation evaluation measures, the investigator's academic-community partnership project is well positioned to create an adaptable and customizable intervention that can be scaled in similar housing populations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 17, 2021

Completed
2.9 years until next milestone

Study Start

First participant enrolled

April 3, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2024

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

January 22, 2026

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

May 12, 2021

Results QC Date

December 11, 2025

Last Update Submit

January 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Nicotine Dependence (Short Form 8a) Score

    This outcome measures assesses cravings or withdrawal that occurs upon brief cessation of smoking, smoking temptations, compulsive use, and tolerance. The scores range from 8 - 40. The lower end of the range indicates no nicotine dependence and the upper end of the range correlates with a high degree of dependence.

    Baseline, 4 weeks

Secondary Outcomes (5)

  • Change in PROMIS Coping Expectancies (Short Form 4a) Score

    Baseline, 4 weeks

  • Change in PROMIS Emotional and Sensory Expectancies (Short Form 6a) Score

    Baseline, 4 weeks

  • Change in PROMIS Health Expectancies (Short Form 6a) Score

    Baseline, 4 weeks

  • Change in PROMIS Psychosocial Expectancies (Short Form 6a) Score

    Baseline, 4 weeks

  • Change in PROMIS Social Motivations (Short Form 4a) Score

    Baseline, 4 weeks

Study Arms (1)

Cessation intervention

EXPERIMENTAL

Participants will undergo pre-/post-comparisons of a personalized, remote smoking cessation intervention composed of two main elements: a) prescription and monitoring of nicotine (e.g., replacement therapy) and/or non-nicotine pharmacotherapies (e.g., varenicline) and b) cessation-centered motivational messaging.

Other: Cessation Intervention

Interventions

1. Pharmacotherapy selection, prescription and monitoring of up to two types of cessation pharmacotherapies: Nicotine replacement therapy (gum, lozenge and transdermal patch) and non-nicotine replacement therapy (varenicline). 2. Remote video-conferencing and mobile phone-based, personalized motivational messaging

Cessation intervention

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years of age to 99 years old
  • Self-reported smoker with either daily or weekly cigarette use, as well as expressed desire to reduce or quit smoking
  • Proof of residence at Douglass or Brooklyn Homes through verbal acknowledgement by the Service Coordinators at each of the public housing sites.
  • Working cell phone with ability to text for the duration of the study
  • Active health insurance (for pharmacotherapy billing)

You may not qualify if:

  • Pregnant - women will verbally acknowledge that they are not pregnant
  • Breastfeeding - women who are verbally acknowledge they are breastfeeding will be excluded from the study.
  • Ongoing participation in a tobacco cessation program or related tobacco intervention study
  • Unable to verbally state that they are willing to reduce or quit smoking upon recruitment and screening
  • Adults lacking capacity to consent
  • Non-English speakers
  • Self-reported usage of only non-combustible tobacco products, such as smokeless tobacco or Electronic Nicotine Delivery Devices (ENDS).
  • Anticipated relocation outside of Douglass or Brooklyn Homes prior to the final study visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Creative Alternative

Baltimore, Maryland, 21224, United States

Location

MeSH Terms

Conditions

Smoking CessationSmoking ReductionTobacco Smoking

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorSmokingTobacco Use

Results Point of Contact

Title
Panagis Galiatsatos, MD, MHS
Organization
Johns Hopkins University School of Medicine

Study Officials

  • Panagis Galiatsatos

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Pre-post study design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2021

First Posted

May 17, 2021

Study Start

April 3, 2024

Primary Completion

October 18, 2024

Study Completion

October 18, 2024

Last Updated

January 22, 2026

Results First Posted

January 22, 2026

Record last verified: 2026-01

Locations